CN103768194A - Traditional Chinese medicine effective part composition for treating rheumatic heart disease - Google Patents
Traditional Chinese medicine effective part composition for treating rheumatic heart disease Download PDFInfo
- Publication number
- CN103768194A CN103768194A CN201310568909.2A CN201310568909A CN103768194A CN 103768194 A CN103768194 A CN 103768194A CN 201310568909 A CN201310568909 A CN 201310568909A CN 103768194 A CN103768194 A CN 103768194A
- Authority
- CN
- China
- Prior art keywords
- part composition
- heart disease
- rheumatic heart
- chinese medicinal
- medicinal effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine effective part composition for treating the rheumatic heart disease, which adopts such raw materials in parts by weight as fructus rosae laevigatae, fruit of princesplume ladysthumb, turtle shell glue, sedum sarmentosum, rhizoma menispermi and myrobalan. The traditional Chinese medicine effective part composition has the effects of opening the inhibited lung-energy, relieving superficies, eliminating phlegm by cooling, tonifying spleen to calm down, invigorating qi and blood, promoting blood circulation to remove blood stasis, warming yang to promote dieresis, tonifying qi and preventing exhaustion, and is effective in treatment of rheumatic heart disease, has no side effects, and is high in safety.
Description
Technical field
The present invention relates to Chinese medicine composition field, be specifically related to a kind of Chinese medicinal effective-part composition that is used for the treatment of rheumatic heart disease.
Background technology
Rheumatic heart disease belongs to common connective tissue disease, repeatedly shows effect and involves heart due to rheumatic fever, causes damaged heart valve and forms.For the pathogeny of rheumatic fever, modern medicine once had multiple theory, but not yet very clear and definite so far, thereby brought certain difficulty to actively preventing and treating rheumatic heart disease.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicinal effective-part composition for the preparation for the treatment of rheumatic heart disease, this active component composition can be treated rheumatic heart disease, and is difficult for recurrence.
Above-mentioned purpose of the present invention is achieved by the following technical programs:
The cause of disease of rheumatic heart disease, western medicine and Chinese medicine are all titled with the name of rheumatism, and both understanding is rather consistent as seen.By vast clinical position person's practice, the cause of disease of rheumatic heart disease is defined as to exopathogenic factor and endogenous cause of ill, outer because the invasion and attack of the heresy of rheumatism are interior because internal organs are deficient.
Treat a Chinese medicinal effective-part composition for rheumatic heart disease, by making according to the raw material of mass fraction meter as follows: Fructus Rosae Laevigatae 30, Fructus Polygoni Orientalis 21, Colla carapax Trionycis 16, Herba Sedi 13, Rhizoma Menispermi 10 and Fructus chebulae immaturus 10.
The preparation method of Chinese medicinal effective-part composition of the present invention be by above-mentioned raw materials compositions according to proportioning combination drying, add 10 times of water gagings, boil with high heat, change slow fire boiling into 3 hours, waste, to obtain final product.
Compared with prior art, the present invention has following beneficial effect:
Find through experiment, the Chinese medicinal effective-part composition of making according to proportioning of the present invention has the effect of diffusing lung, relieving exterior syndrome, removing heat-phlegm, spleen invigorating mind calming, benefiting vital QI and blood, blood circulation promoting and blood stasis dispelling, warming YANG to promote diuresis, supplementing QI to prevent collapse, can be used for the treatment of rheumatic heart disease, after curing, be difficult for recurrence.
The specific embodiment
Further explain the present invention below in conjunction with embodiment, but embodiment does not limit in any form to the present invention.
embodiment 1
Fructus Rosae Laevigatae 30g, Fructus Polygoni Orientalis 21g, Colla carapax Trionycis 16g, Herba Sedi 13g, Rhizoma Menispermi 10g and Fructus chebulae immaturus 10g, add 10 times of water gagings after being dried, and after boiling, then uses slow fire decocting 180min with intense fire, and gained decoction is for subsequent use.
embodiment 2
500 of clinical observation Patients With Rheumatic Valvular Diseases.Patient is all diagnosed as rheumatic heart disease through clinical diagnosis.Take embodiment 1 gained decoction to patient, 2 times on the 1st, sooner or later bfore meals, continuous 30 days.
Take patient's statistical result of embodiment 1 gained decoction in table 1.Wherein fully recover and effectively, fully recover and refer to that sings and symptoms disappears substantially effective comprising, can be competent at routine work and housework; Effectively refer to that clinical symptoms and sign are progressive to some extent, can participate in slight physical work.Invalidly refer to that, through treatment, symptom and sign are all unchanged or increase the weight of, even dead.
Table 1
Number of cases | Effective | Invalid | Obvious effective rate (%) |
500 | 484 | 16 | 96.8 |
Known by above-mentioned data, Chinese medicine of the present invention is made after decoction, can be in 30 days the treatment rheumatic heart disease of highly significant.
embodiment 3
The decoction administration ICR mice that uses embodiment 1 to make, body weight 20 ~ 25g, male and female half and half, successive administration 120d.
Through prerun, the decoction toxicity that embodiment 1 makes is very low, does not measure LD50, measures therefore mice is carried out to maximum dosage-feeding on the one.Maximum dosage-feeding is 400ml/d, observes none example and be poisoned to death after 120 days, and all healthy survival, proves that the decoction that compositions of the present invention is made can toxic side effect to human body thus.
Claims (4)
1. treat a Chinese medicinal effective-part composition for rheumatic heart disease, it is characterized in that by making according to the raw material of mass fraction meter as follows: Fructus Rosae Laevigatae 30, Fructus Polygoni Orientalis 21, Colla carapax Trionycis 16, Herba Sedi 13, Rhizoma Menispermi 10 and Fructus chebulae immaturus 10.
2. the Chinese medicinal effective-part composition for the treatment of rheumatic heart disease according to claim 1, is characterized in that described Chinese medicinal effective-part composition makes decoction.
3. described in claim 1 or 2, treat the preparation method of the Chinese medicinal effective-part composition of rheumatic heart disease, it is characterized in that each crude drug, according to proportioning combination drying, adding 10 times of water gagings, boil with high heat, change slow fire boiling into 3 hours, waste, to obtain final product.
4. the application of Chinese medicinal effective-part composition described in claim 1 or 2, is characterized in that the medicine of described Chinese medicinal effective-part composition for the preparation for the treatment of rheumatic heart disease.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310568909.2A CN103768194A (en) | 2013-11-15 | 2013-11-15 | Traditional Chinese medicine effective part composition for treating rheumatic heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310568909.2A CN103768194A (en) | 2013-11-15 | 2013-11-15 | Traditional Chinese medicine effective part composition for treating rheumatic heart disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103768194A true CN103768194A (en) | 2014-05-07 |
Family
ID=50561254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310568909.2A Pending CN103768194A (en) | 2013-11-15 | 2013-11-15 | Traditional Chinese medicine effective part composition for treating rheumatic heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103768194A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547448A (en) * | 2015-01-23 | 2015-04-29 | 张成杰 | Traditional Chinese medicine composition for treating rheumatic heart disease |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1583107A (en) * | 2004-05-26 | 2005-02-23 | 内蒙古草原兴发股份有限公司 | Health care product of chicken's gizzard skin and its preparation |
-
2013
- 2013-11-15 CN CN201310568909.2A patent/CN103768194A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1583107A (en) * | 2004-05-26 | 2005-02-23 | 内蒙古草原兴发股份有限公司 | Health care product of chicken's gizzard skin and its preparation |
Non-Patent Citations (1)
Title |
---|
高尔鑫: "心脏疾病中医辨治的理论与思路探析", 《安徽中医学院学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547448A (en) * | 2015-01-23 | 2015-04-29 | 张成杰 | Traditional Chinese medicine composition for treating rheumatic heart disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104771658A (en) | Traditional Chinese medicine composition for treating cough | |
CN103768194A (en) | Traditional Chinese medicine effective part composition for treating rheumatic heart disease | |
CN101983682A (en) | Medicament for treating female climacteric metancholia | |
CN103432333B (en) | Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism | |
CN101229338B (en) | Heat cough oral liquid | |
CN104474256A (en) | Oral liquor for treating acquired immunodeficiency syndrome lung infection | |
CN103768341A (en) | Traditional Chinese medicine effective part composition for treating primary glaucoma | |
CN101983719A (en) | Novel medicament for treating lung cancer | |
CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation | |
CN103768312A (en) | Traditional Chinese medicine effective part composition for treating Meniere's disease | |
CN106177561A (en) | One treats phthisical Chinese medicine composition | |
CN103768150A (en) | Traditional Chinese medicine effective part composition for treating cataract | |
CN103550592A (en) | Traditional Chinese medicinal effective part composition for treating priapism | |
CN104107294A (en) | Traditional Chinese medicine preparation used for treating chronic bronchitis, and preparation method and application thereof | |
CN104984054A (en) | Traditional Chinese medicine composition for treating asthma | |
CN103432301B (en) | Traditional Chinese medicine effective part composition for treating primary adrenocortical insufficiency | |
CN103550294B (en) | Traditional Chinese medicine effective part composition for treating urticaria | |
CN104398596A (en) | Traditional Chinese medicinal formula for treating oral ulcer | |
CN103223157B (en) | Traditional Chinese medicine composition used for treating cold | |
CN103638433B (en) | One treats pleuritic pure Chinese medicine composition | |
CN103550295A (en) | Traditional Chinese medicine effective part composition for treating acne | |
CN103432397B (en) | Traditional Chinese medicine effective part composition for treating thromboangiitis obliterans | |
CN104258231A (en) | Traditional Chinese medicine composition for treating cough | |
CN103263547B (en) | Traditional Chinese medicinal preparation for treating urticaria papulosa | |
CN102836404B (en) | Chinese medicine for treating chronic nephritis by using ludwigia octovalvis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20160316 |
|
C20 | Patent right or utility model deemed to be abandoned or is abandoned |